ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly net change in short-term borrowings ($M) ($M)
Quarterly figures from Eli Lilly's filings and investor materials
Latest, Q2 2026
3,509
Period ended Jun 30, 2026
Change on a year earlier
+118.9%
1,603 in Q2 2025
History
58 quarters
Since Q3 2008
Sources
41
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net change in short-term borrowings ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 3,509 | +118.9% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,775 | -196.0% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | -0.40 | -100.0% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | -4,092 | +32.4% | Form 10-Q (filed 2026-08-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 1,603 | -52.9% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | -1,849 | -64.5% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 3,042 | -33.8% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | -3,089 | -293.7% | Form 10-Q (filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 3,400 | – | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | -5,205 | +247.4% | Form 10-Q (filed 2024-04-30) ↗ |
| Q4 2023 | Dec 31, 2023 | 4,594 | -1,988.2% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,595 | -524.3% | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2023 | Jun 30, 2023 | 0 | -100.0% | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2023 | Mar 31, 2023 | -1,498 | -399.8% | Form 10-Q (filed 2023-04-27) ↗ |
| Q4 2022 | Dec 31, 2022 | -243 | – | Form 10-Q (filed 2023-11-02) ↗ |
| Q3 2022 | Sep 30, 2022 | -376 | – | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,618 | – | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 500 | – | Form 10-Q (filed 2023-04-27) ↗ |
| Q2 2019 | Jun 30, 2019 | -286 | -130.0% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,850 | -253.9% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2018 | Dec 31, 2018 | 99.2 | -41.9% | Form 10-K (filed 2019-02-19) ↗ |
| Q3 2018 | Sep 30, 2018 | -2,048 | -286.0% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 954 | -356.5% | Form 10-Q (filed 2018-07-25) ↗ |
| Q1 2018 | Mar 31, 2018 | -1,203 | -341.7% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 171 | -86.8% | Form 10-K (filed 2018-02-20) ↗ |
| Q3 2017 | Sep 30, 2017 | 1,101 | -367,133.3% | Form 10-Q (filed 2017-10-27) ↗ |
| Q2 2017 | Jun 30, 2017 | -372 | +123,833.3% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | 498 | -45,327.3% | Form 10-Q (filed 2017-05-01) ↗ |
| Q4 2016 | Dec 31, 2016 | 1,295 | +1,294,800.0% | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2016 | Sep 30, 2016 | -0.30 | -78.6% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | -0.30 | -99.9% | Form 10-Q (filed 2016-07-28) ↗ |
| Q1 2016 | Mar 31, 2016 | -1.10 | -99.9% | Form 10-Q (filed 2016-04-29) ↗ |
| Q4 2015 | Dec 31, 2015 | 0.10 | -100.0% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2015 | Sep 30, 2015 | -1.40 | -100.5% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | -591 | -25,782.6% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2015 | Mar 31, 2015 | -2,089 | – | Form 10-Q (filed 2015-04-30) ↗ |
| Q4 2014 | Dec 31, 2014 | 2,376 | – | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2014 | Sep 30, 2014 | 303 | – | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | 2.30 | – | Form 10-Q (filed 2015-04-30) ↗ |
| Q1 2014 | Mar 31, 2014 | 0 | – | Form 10-Q (filed 2015-04-30) ↗ |
| Q2 2013 | Jun 30, 2013 | 0 | -100.0% | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2013 | Mar 31, 2013 | 0 | -100.0% | Form 10-Q (filed 2013-04-26) ↗ |
| Q4 2012 | Dec 31, 2012 | 6.70 | – | Form 10-K (filed 2014-02-19) ↗ |
| Q3 2012 | Sep 30, 2012 | 0 | -100.0% | Form 10-Q (filed 2013-10-30) ↗ |
| Q2 2012 | Jun 30, 2012 | -1.40 | – | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2012 | Mar 31, 2012 | -5.30 | -95.4% | Form 10-Q (filed 2013-04-26) ↗ |
| Q2 2011 | Sep 30, 2011 | 87.6 | -30.7% | Form 10-Q (filed 2011-10-28) ↗ |
| Q1 2011 | Mar 31, 2011 | -116 | +1,370.9% | Form 10-Q (filed 2011-04-29) ↗ |
| Q4 2010 | Dec 31, 2010 | 0 | -100.0% | Form 10-K (filed 2013-02-21) ↗ |
| Q3 2010 | Sep 30, 2010 | 126 | -861.4% | Form 10-Q (filed 2010-10-29) ↗ |
| Q2 2010 | Jun 30, 2010 | 6.60 | -101.2% | Form 10-Q/A (filed 2010-08-02) ↗ |
| Q1 2010 | Mar 31, 2010 | -7.90 | -99.8% | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2009 | Dec 31, 2009 | -995 | -118.2% | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2009 | Sep 30, 2009 | -16.6 | -61.3% | Form 10-Q (filed 2009-10-30) ↗ |
| Q2 2009 | Jun 30, 2009 | -569 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q1 2009 | Mar 31, 2009 | -4,244 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2008 | Dec 31, 2008 | 5,453 | – | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2008 | Sep 30, 2008 | -42.9 | – | Form 10-Q (filed 2009-10-30) ↗ |
Cite this data
StockData. (2026). Eli Lilly Net change in short-term borrowings ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_st_debt_net
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.